ClinVar Miner

Submissions for variant NM_001042492.3(NF1):c.584A>G (p.Lys195Arg)

gnomAD frequency: 0.00001  dbSNP: rs587778552
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000166667 SCV000217472 uncertain significance Hereditary cancer-predisposing syndrome 2016-01-14 criteria provided, single submitter clinical testing The p.K195R variant (also known as c.584A>G), located in coding exon 5 of the NF1 gene, results from an A to G substitution at nucleotide position 584. The lysine at codon 195 is replaced by arginine, an amino acid with highly similar properties. This alteration was reported with an allele frequency of 0.007in a cohort of 681 healthy individuals undergoing whole genome sequencing (Bodian et al.PLoS ONE; 9(4):e94554).This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6500 samples (13000 alleles) with coverage at this position.<span style="background-color:initial">To date, this alteration has been detected with an allele frequency of approximately 0.005% (greater than 110000 alleles tested) in our clinical cohort.<span style="background-color:initial">This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis.<span style="background-color:initial">Since supporting evidence is limited at this time, the clinical significance of<span style="background-color:initial">p.K195R<span style="background-color:initial">remains unclear.
Invitae RCV000691511 SCV000819294 uncertain significance Neurofibromatosis, type 1 2024-01-20 criteria provided, single submitter clinical testing This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 195 of the NF1 protein (p.Lys195Arg). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with personal or family history of breast and/or ovarian cancer (PMID: 31159747). ClinVar contains an entry for this variant (Variation ID: 134888). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneKor MSA RCV000166667 SCV000822099 uncertain significance Hereditary cancer-predisposing syndrome 2018-08-01 criteria provided, single submitter clinical testing
Centre for Mendelian Genomics, University Medical Centre Ljubljana RCV000691511 SCV001367190 uncertain significance Neurofibromatosis, type 1 2019-03-01 criteria provided, single submitter clinical testing This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PM1,BP4.
GeneDx RCV001762266 SCV002008386 uncertain significance not provided 2021-05-19 criteria provided, single submitter clinical testing Observed in individuals referred for hereditary cancer genetic testing (Tsaousis et al., 2019); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 31159747, 24728327)
Genome-Nilou Lab RCV000691511 SCV002561485 uncertain significance Neurofibromatosis, type 1 2022-03-15 criteria provided, single submitter clinical testing
Medical Genetics, University of Parma RCV000691511 SCV002567758 likely benign Neurofibromatosis, type 1 2022-08-17 criteria provided, single submitter clinical testing
ITMI RCV000121637 SCV000085835 not provided not specified 2013-09-19 no assertion provided reference population

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.